Cardioprotective effect of therapeutic hypothermia for postresuscitation myocardial dysfunction

Shock

Volumn 32, Issue 2, 2009, Pages 210-216

  Hsu, Chiung Yuan ^a   Huang, Chien Hua ^a   Chang, Wei Tien ^a   Chen, Huei Wen ^b   Cheng, Hsiao Ju ^a   Tsai, Min Shan ^a   Wang, Tzung Dau ^c   Yen, Zui Shen ^a   Lee, Chien Chang ^a   Chen, Shyr Chyr ^a   Chen, Wen Jone ^a,d,e  

^a NATIONAL TAIWAN UNIVERSITY   (Taiwan)

^b NATIONAL YANG MING UNIVERSITY   (Taiwan)

^c NATIONAL TAIWAN UNIVERSITY HOSPITAL   (Taiwan)

^d TAO YUAN GENERAL HOSPITAL   (Taiwan)

^e NONE   (Taiwan)

Author keywords

Akt; Cardiopulmonary resuscitation; ERK; Heart failure; Hypothermia; Postresuscitation

Indexed keywords

MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; PROTEIN KINASE B BETA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; ECHOCARDIOGRAPHY; ENZYME ACTIVITY; HEART ARREST; HEART FAILURE; HEART LEFT VENTRICLE DP-DT; HEART PROTECTION; INDUCED HYPOTHERMIA; MALE; NONHUMAN; RAT; RESUSCITATION; SURVIVAL RATE;

ANIMALS; ASPHYXIA; ECHOCARDIOGRAPHY; EPINEPHRINE; FATTY ACID-BINDING PROTEINS; HEART ARREST; HYPOTHERMIA, INDUCED; MALE; MITOGEN-ACTIVATED PROTEIN KINASE 1; MITOGEN-ACTIVATED PROTEIN KINASE 3; MYOCARDIUM; PROTO-ONCOGENE PROTEINS C-AKT; RATS; RATS, WISTAR; RESUSCITATION; SIGNAL TRANSDUCTION; SYMPATHOMIMETICS; SYSTOLE; TIME FACTORS;

EID: 67749117941     PISSN: 10732322     EISSN: None     Source Type: Journal    
DOI: 10.1097/SHK.0b013e318196ee99     Document Type: Article

References (49)

1. El-Menyar AA: The resuscitation outcome: revisit the story of the stony heart. Chest 128:2835-2846, 2005.
2. Gross GJ, Kersten JR, Warltier DC: Mechanical of post-ischemic contractile dysfunction. Ann Thorac Surg 68:1898-1904, 1999.
3. Laurent I, Monchi M, Chiche JD, Joly LM, Spaulding C, Bourgeois B, Cariou A, Rozenberg A, Carli P, Weber S, et al.: Reversible myocardial dysfunction in survivors of out-of-hospital cardiac arrest. J Am Coll Cardiol 40:2110-2116, 2002.
4. A randomized clinical study of a calcium-entry blocker (lidoflazine) in the treatment of comatose survivors of cardiac arrest. Brain Resuscitation Clinical Trial II Study Group. N Engl J Med 324:1225-1231, 1991.
5. Cerchiari EL, Safar P, Klein E, Cantadore R, Pinsky M: Cardiovascular function and neurologic outcome after cardiac arrest in dogs. The cardiovascular post-resuscitation syndrome. Resuscitation 25:9-33, 1993.
6. Edgren E, Hedstrand U, Kelsey S, Sutton-Tyrrell K, Safar P: Assessment of neurological prognosis in comatose survivors of cardiac arrest. BRCT I Study Group. Lancet 343:1055-1059, 1994.
7. Becker LB, Ostrander MP, Barrett J, Kondos GT: Outcome of CPR in a large metropolitan area - where are the survivors? Ann Emerg Med 20:355-361, 1991.
8. American Heart Association. International consensus on cardiopulmonary resuscitation and emergency cardiovascular care science with treatment recommendations. Circulation 112(suppl 1):1-136, 2005.
9. Fukuda H, Tomimatsu T, Watanabe N, Mu JW, Kohzuki M, Endo M, Fujii E, Kanzaki T, Murata Y: Post-ischemic hypothermia blocks caspase-3 activation in the newborn rat brain after hypoxia-ischemia. Brain Res 910:187-191, 2001.
10. Lei B, Tan X, Cai H, Xu Q, Guo Q: Effect of moderate hypothermia on lipid peroxidation in canine brain tissue after cardiac arrest and resuscitation. Stroke 25:147-152, 1994.
11. Mild therapeutic hypothermia to improve the neurologic outcome after cardiac arrest. N Engl J Med 346:549-556, 2002.
12. Bernard SA, Gray TW, Buist MD, Jones BM, Silvester W, Gutteridge G, Smith K: Treatment of comatose survivors of out-of-hospital cardiac arrest with induced hypothermia. N Engl J Med 346:557-563, 2002.
13. Hodt A, Steine K, Atar D: Medical and ventilatory treatment of acute heart failure: new insights. Cardiology 106:1-9, 2006.
14. Huang L, Weil MH, Sun S, Cammarata G, Cao L, Tang W: Levosimendan improves postresuscitation outcomes in a rat model of CPR. J Lab Clin Med 146:256-261, 2005.
15. Mebazaa A, Karpati P, Renaud E, Algotsson L: Acute right ventricular failure - from pathophysiology to new treatments. Intensive Care Med 30:185-196, 2004.
16. Tennyson H, Kern KB, Hilwig RW, Berg RA, Ewy GA: Treatment of post resuscitation myocardial dysfunction: aortic counterpulsation versus dobutamine. Resuscitation 54:69-75, 2002.
17. Danzl DF, Pozos RS: Accidental hypothermia. N Engl J Med 331:1756-1760, 1994.
18. Steinman AM: Cardiopulmonary resuscitation and hypothermia. Circulation 74:IV29-IV32, 1986.
19. Tveita T, Skandfer M, Refsum H, Ytrehus K: Experimental hypothermia and rewarming: changes in mechanical function and metabolism of rat hearts. J Appl Physiol 80:291-297, 1996.
20. Ning XH, Xu CS, Song YC, Childs KF, Xiao Y, Bolling SF, Lupinetti FM, Portman MA: Temperature threshold and modulation of energy metabolism in the cardioplegic arrested rabbit heart. Cryobiology 36:2-11, 1998.
21. Palo M, Lauri T, Timisjarvi J: Effects on dogs of surface-induced hypothermia and rewarming on the right heart function and pulmonary circulation. Eur J Appl Physiol 81:391-396, 2000.
22. Tveita T, Ytrehus K, Myhre ES, Hevroy O: Left ventricular dysfunction following rewarming from experimental hypothermia. J Appl Physiol 85:2135-2139, 1998.
23. Weisser J, Martin J, Bisping E, Maier LS, Beyersdorf F, Hasenfuss G, Pieske B: Influence of mild hypothermia on myocardial contractility and circulatory function. Basic Res Cardiol 96:198-205, 2001.
24. Merchant RM, Soar J, Skrifvars MB, Silfvast T, Edelson DP, Ahmad F, Huang KN, Khan M, Vanden Hoek TL, Becker LB, et al.: Therapeutic hypothermia utilization among physicians after resuscitation from cardiac arrest. Crit Care Med 34:1935-1940, 2006.
25. Laver SR, Padkin A, Atalla A, Nolan JP: Therapeutic hypothermia after cardiac arrest: a survey of practice in intensive care units in the United Kingdom. Anaesthesia 61:873-877, 2006.
26. Nolan JP, Morley PT, Vanden Hoek TL, Hickey RW, Kloeck WG, Billi J, Bottiger BW, Okada K, Reyes C, Shuster M, et al.: Therapeutic hypothermia after cardiac arrest: an advisory statement by the advanced life support task force of the International Liaison Committee on Resuscitation. Circulation 108:118-121, 2003.
27. Wolfrum S, Radke PW, Pischon T, Willich SN, Schunkert H, Kurowski V: Mild therapeutic hypothermia after cardiac arrest - a nationwide survey on the implementation of the ILCOR guidelines in German intensive care units. Resuscitation 72:207-213, 2007.
28. Skulec R, Kovarnik T, Dostalova G, Kolar J, Linhart A: Induction of mild hypothermia in cardiac arrest survivors presenting with cardiogenic shock syndrome. Acta Anaesthesiol Scand 52:188-194, 2008.
29. Dae M, Gao D, Sessler D, Chair K, Stillson C: Effect of endovascular cooling on myocardial temperature, infarct size, and cardiac output in human-sized pigs. Am J Physiol 282:H1584-H1591, 2002.
30. Hale SL, Kloner RA: Myocardial temperature reduction attenuates necrosis after prolonged ischemia in rabbits. Cardiovasc Res 40:502-507, 1998.
31. Hale SL, Dae MW, Kloner RA: Hypothermia during reperfusion limits 'no-reflow' injury in a rabbit model of acute myocardial infarction. Cardiovasc Res 59:715-722, 2003.
32. Boyer NH, Gerstein MM: Induced hypothermia in dogs with acute myocardial infarction and shock. J Thorac Cardiovasc Surg 74:286-294, 1997.
33. van den Doel MA, Gho BC, Duval SY, Schoemaker RG, Duncker DJ, Verdouw PD: Hypothermia extends the cardioprotection by ischaemic preconditioning to coronary artery occlusions of longer duration. Cardiovasc Res 37:76-81, 1998.
34. Ning XH, Chen SH, Xu CS, Hyyti OM, Qian K, Krueger JJ, Portman MA: Hypothermia preserves myocardial function and mitochondrial protein gene expression during hypoxia. Am J Physiol Heart Circ Physiol 285:H212-H219, 2003.
35. Abella BS, Zhao D, Alvarado J, Hamann K, Vanden Hoek TL, Becker LB: Intra-arrest cooling improves outcomes in a murine cardiac arrest model. Circulation 109:2786-2791, 2004.
36. Suzuki K, Sawa Y, Kadoba K, Takahashi T, Ichikawa H, Kagisaki K, Ohata T, Matsuda H: Early detection of cardiac damage with heart fatty acid - binding protein after cardiac operations. Ann Thorac Surg 65:54-58, 1998.
37. Tanaka T, Hirota Y, Sohmiya K, Nishimura S, Kawamura K: Serum and urinary human heart fatty acid - binding protein in acute myocardial infarction. Clin Biochem 24:195-201, 1991.
38. O'Donoghue M, de Lemos JA, Morrow DA, Murphy SA, Buros JL, Cannon CP, Sabatine MS: Prognostic utility of heart-type fatty acid binding protein in patients with acute coronary syndromes. Circulation 11:550-557, 2006.
39. Iida K, Nagao K, Uchiyama T, Kushiro T: Relationship between heart-type fatty acid-binding protein levels and the risk of death in patients with serious condition on arrival at the emergency department. Intern Med 44:1039-1045, 2005.
40. Komamura K, Sasaki T, Hanatani A, Kim J, Hashimura K, Ishida Y, Ohkaru Y, Asayama K, Tanaka T, Ogai A, et al.: Heart-type fatty acid binding protein is a novel prognostic marker in patients with non-ischaemic dilated cardiomyopathy. Heart 92:615-618, 2006.
41. Niizeki T, Takeishi Y, Arimoto T, Takahashi T, Okuyama H, Takabatake N, Nozaki N, Hirono O, Tsunoda Y, Shishido T, et al.: Combination of heart-type fatty acid binding protein and brain natriuretic peptide can reliably risk stratify patients hospitalized for chronic heart failure. Circ J 69:922-927, 2005.
42. Weisfeldt ML, Becker LB: Resuscitation after cardiac arrest: a 3-phase time-sensitive model. JAMA 288:3035-3038, 2002.
43. Armstrong SC: Protein kinase activation and myocardial ischemia/reperfusion injury. Cardiovasc Res 61:427-436, 2004.
44. Johnson GL, Lapadat R: Mitogen-activated protein kinase pathways mediated by ERK, JNK, and p38 protein kinases. Science 298:1911-1912, 2002.
45. Wada T, Penninger JM: Mitogen-activated protein kinases in apoptosis regulation. Oncogene 23:2838-2849, 2004.
46. Hausenloy DJ, Yellon DM: New directions for protecting the heart against ischaemia-reperfusion injury: targeting the reperfusion injury salvage kinase (RISK)-pathway. Cardiovasc Res 61:448-460, 2004.
47. Ning XH, Chi EY, Buroker NE, Chen SH, Xu CS, Tien YT, Hyyti OM, Ge M, Portman MA: Moderate hypothermia (30 degrees C) maintains myocardial integrity and modifies response of cell survival proteins after reperfusion. Am J Physiol Heart Circ Physiol 293:H2119-H2128, 2007.
48. Clanachan AS, Jaswal JS, Gandhi M, Bottorff DA, Coughlin J, Finegan BA, Stone JC: Effects of inhibition of myocardial extracellular-responsive kinase and P38 mitogen - activated protein kinase on mechanical function of rat hearts after prolonged hypothermic ischemia. Transplantation 75:173-180, 2003.
49. Huang CH, Hsu CY, Chen HW, Tsai MS, Cheng HJ, Chang CH, Lee YT, Chen WJ: Erythropoietin improves the postresuscitation myocardial dysfunction and survival in the asphyxia-induced cardiac arrest model. Shock 28:53-58, 2007.